APA (7th ed.) Citation

C, P., ME, T., RS, M., K, C., H, X., G, P., . . . WC, D. (2026). Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: A randomized, flexible-dose, 6-month, parallel-group, exploratory study. The international journal of neuropsychopharmacology, 29(4), . https://doi.org/10.1093/ijnp/pyag009

Chicago Style (17th ed.) Citation

C, Pinter, Thase ME, McIntyre RS, Cooper K, Xu H, Pandina G, Savitz A, and Drevets WC. "Safety, Tolerability, and Preliminary Efficacy of Seltorexant Versus Quetiapine Extended Release as Adjunctive Therapy in Major Depressive Disorder: A Randomized, Flexible-dose, 6-month, Parallel-group, Exploratory Study." The International Journal of Neuropsychopharmacology 29, no. 4 (2026). https://doi.org/10.1093/ijnp/pyag009.

MLA (9th ed.) Citation

C, Pinter, et al. "Safety, Tolerability, and Preliminary Efficacy of Seltorexant Versus Quetiapine Extended Release as Adjunctive Therapy in Major Depressive Disorder: A Randomized, Flexible-dose, 6-month, Parallel-group, Exploratory Study." The International Journal of Neuropsychopharmacology, vol. 29, no. 4, 2026, https://doi.org/10.1093/ijnp/pyag009.